Evidence map›Paper›PMID 32315321›Full record

ArticlePloS one2020

Dysregulated activities of proline-specific enzymes in septic shock patients (sepsis-2).

Gwendolyn Vliegen, Kaat Kehoe, An Bracke, Emilie De Hert, Robert Verkerk, Erik Fransen, Bart 's Jongers, Esther Peters, Anne-Marie Lambeir, Samir Kumar-Singh and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Identification and validation of mFrontiers in immunology · 2025
    Article
  6. Review
  7. Article
  8. Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients.Clinica chimica acta; international journal of clinical chemistry · 2022
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Gwendolyn VliegenLaboratory of Medical Biochemistry, University of Antwerp, Antwerp, Belgium.ORCID 0000-0002-0915-2444
Kaat KehoeLaboratory of Medical Biochemistry, University of Antwerp, Antwerp, Belgium.
An BrackeLaboratory of Medical Biochemistry, University of Antwerp, Antwerp, Belgium.
Emilie De HertLaboratory of Medical Biochemistry, University of Antwerp, Antwerp, Belgium.ORCID 0000-0002-6094-4455
Robert VerkerkLaboratory of Medical Biochemistry, University of Antwerp, Antwerp, Belgium.
Erik FransenStatUa Center for Statistics, University of Antwerp, Antwerp, Belgium.
Bart 's JongersMolecular Pathology Group, Cell Biology and Histology, University of Antwerp, Antwerp, Belgium.
Esther PetersDepartment of Intensive Care Medicine, Radboud university medical center, Nijmegen, The Netherlands.
Anne-Marie LambeirLaboratory of Medical Biochemistry, University of Antwerp, Antwerp, Belgium.
Samir Kumar-SinghMolecular Pathology Group, Cell Biology and Histology, University of Antwerp, Antwerp, Belgium.
Peter PickkersDepartment of Intensive Care Medicine, Radboud university medical center, Nijmegen, The Netherlands.
Philippe G JorensDepartment of Critical Care Medicine, Antwerp University Hospital, Edegem, Belgium and Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.
Ingrid De MeesterLaboratory of Medical Biochemistry, University of Antwerp, Antwerp, Belgium.
University of Antwerp · BERadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proline-specific enzymes dipeptidyl peptidase 4 (DPP4), prolylcarboxypeptidase (PRCP), fibroblast activation protein α (FAP) and prolyl oligopeptidase (PREP) are known for their involvement in the immune system and blood pressure regulation. Only very limited information is currently available on their enzymatic activity and possible involvement in patients with sepsis and septic-shock. The activity of the enzymes was measured in EDTA-plasma of patients admitted to the intensive care unit (ICU): 40 septic shock patients (sepsis-2) and 22 ICU control patients after major intracranial surgery. These data were used to generate receiver operating characteristic (ROC) curves. A survival analysis (at 90 days) and an association study with other parameters was performed. PRCP (day 1) and PREP (all days) enzymatic activities were higher in septic shock patients compared to controls. In contrast, FAP and DPP4 were lower in these patients on all studied time points. Since large differences were found, ROC curves were generated and these yielded area under the curve (AUC) values for PREP, FAP and DPP4 of 0.88 (CI: 0.80-0.96), 0.94 (CI: 0.89-0.99) and 0.86 (CI: 0.77-0.95), respectively. PRCP had a lower predicting value with an AUC of 0.71 (CI: 0.58-0.83). A nominally significant association was observed between survival and the DPP4 enzymatic activity at day 1 (p<0.05), with a higher DPP4 activity being associated with an increase in survival. All four enzymes were dysregulated in septic shock patients. DPP4, FAP and PREP are good in discriminating between septic shock patients and ICU controls and should be further explored to see whether they are already dysregulated in earlier stages, opening perspectives for their further investigation as biomarkers in sepsis. DPP4 also shows potential as a prognostic biomarker. Additionally, the associations found warrant further research.

Indexed as

Area Under CurveBiomarkersCarboxypeptidasesCritical CareDipeptidyl Peptidase 4EndopeptidasesFemaleFibroblast Activation Protein AlphaGelatinasesHumansLongitudinal StudiesMaleMembrane ProteinsMiddle AgedProlineProlyl OligopeptidasesBiomarkersCarboxypeptidasesDipeptidyl Peptidase 4DPP4 protein, humanEndopeptidasesFibroblast Activation Protein AlphaGelatinaseslysosomal Pro-X carboxypeptidaseMembrane ProteinsPREPL protein, humanProlineProlyl OligopeptidasesSerine Endopeptidases

Identifiers

PMID32315321
PMCPMC7173796
OpenAlexW3016380543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.